Suppliers and packages for generic ingredient: UPADACITINIB
✉ Email this page to a colleague
UPADACITINIB
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Abbvie | RINVOQ LQ | upadacitinib | SOLUTION;ORAL | 218347 | NDA | AbbVie Inc. | 0074-2320-01 | 1 BOTTLE in 1 CARTON (0074-2320-01) / 180 mL in 1 BOTTLE | 2024-04-26 |
| Abbvie | RINVOQ LQ | upadacitinib | SOLUTION;ORAL | 218347 | NDA | AbbVie Inc. | 0074-2320-70 | 1 BOTTLE in 1 CARTON (0074-2320-70) / 180 mL in 1 BOTTLE | 2024-04-26 |
| Abbvie | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675 | NDA | AbbVie Inc. | 0074-1043-14 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-14) | 2019-08-16 |
| Abbvie | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675 | NDA | AbbVie Inc. | 0074-1043-28 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-1043-28) | 2019-08-16 |
| Abbvie | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675 | NDA | AbbVie Inc. | 0074-2306-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-30) | 2019-08-16 |
| Abbvie | RINVOQ | upadacitinib | TABLET, EXTENDED RELEASE;ORAL | 211675 | NDA | AbbVie Inc. | 0074-2306-70 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-2306-70) | 2019-08-16 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
